Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

Metabolic biomarker based BRAFV600 mutation association and prediction in melanoma

Hanna Saadani, Bernies van der Hiel, Else A. Aalbersberg, Ioannis Zavrakidis, John B.A.G. Haanen, Otto S. Hoekstra, Ronald Boellaard and Marcel P.M. Stokkel
Journal of Nuclear Medicine September 2019, jnumed.119.228312; DOI: https://doi.org/10.2967/jnumed.119.228312
Hanna Saadani
1 Netherlands Cancer Institute, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernies van der Hiel
1 Netherlands Cancer Institute, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Else A. Aalbersberg
1 Netherlands Cancer Institute, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ioannis Zavrakidis
1 Netherlands Cancer Institute, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John B.A.G. Haanen
1 Netherlands Cancer Institute, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto S. Hoekstra
2 Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald Boellaard
2 Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcel P.M. Stokkel
1 Netherlands Cancer Institute, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.119.228312
DOI 
https://doi.org/10.2967/jnumed.119.228312
PubMed 
31481581

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online September 3, 2019.

Article Versions

  • You are currently viewing a previous version of this article (September 3, 2019 - 07:12).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2019 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Hanna Saadani1,
  2. Bernies van der Hiel1,
  3. Else A. Aalbersberg1,
  4. Ioannis Zavrakidis1,
  5. John B.A.G. Haanen1,
  6. Otto S. Hoekstra2,
  7. Ronald Boellaard2 and
  8. Marcel P.M. Stokkel1
  1. 1 Netherlands Cancer Institute, Netherlands;
  2. 2 Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Netherlands
  1. For correspondence or reprints contact: Bernies van der Hiel, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, Netherlands. E-mail: b.vd.hiel@nki.nl

Statistics from Altmetric.com

Cited By...

  • 19 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • The Dark Side of Radiomics: On the Paramount Importance of Publishing Negative Results
    Irène Buvat, Fanny Orlhac
    Journal of Nuclear Medicine 2019 60 11
  • A Systematic Review of PET Textural Analysis and Radiomics in Cancer
    Manuel Piñeiro-Fiel, Alexis Moscoso, Virginia Pubul, Álvaro Ruibal, Jesús Silva-Rodríguez, Pablo Aguiar
    Diagnostics 2021 11 2
  • Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response
    Fabio Valenti, Italia Falcone, Sara Ungania, Flora Desiderio, Patrizio Giacomini, Chiara Bazzichetto, Fabiana Conciatori, Enzo Gallo, Francesco Cognetti, Gennaro Ciliberto, Aldo Morrone, Antonino Guerrisi
    International Journal of Molecular Sciences 2021 22 8
  • The Role and Potential of 18F-FDG PET/CT in Malignant Melanoma: Prognostication, Monitoring Response to Targeted and Immunotherapy, and Radiomics
    Luca Filippi, Francesco Bianconi, Orazio Schillaci, Angela Spanu, Barbara Palumbo
    Diagnostics 2022 12 4
  • Clinical application of AI-based PET images in oncological patients
    Jiaona Dai, Hui Wang, Yuchao Xu, Xiyang Chen, Rong Tian
    Seminars in Cancer Biology 2023 91
  • Systematic Review on the Association of Radiomics with Tumor Biological Endpoints
    Agustina La Greca Saint-Esteven, Diem Vuong, Fabienne Tschanz, Janita E. van Timmeren, Riccardo Dal Bello, Verena Waller, Martin Pruschy, Matthias Guckenberger, Stephanie Tanadini-Lang
    Cancers 2021 13 12
  • Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process–A systematic review
    Antonino Guerrisi, Emiliano Loi, Sara Ungania, Michelangelo Russillo, Vicente Bruzzaniti, Fulvia Elia, Flora Desiderio, Raffaella Marconi, Francesco Maria Solivetti, Lidia Strigari
    Cancer Medicine 2020 9 5
  • The human melanoma proteome atlas—Defining the molecular pathology
    Lazaro Hiram Betancourt, Jeovanis Gil, Yonghyo Kim, Viktória Doma, Uğur Çakır, Aniel Sanchez, Jimmy Rodriguez Murillo, Magdalena Kuras, Indira Pla Parada, Yutaka Sugihara, Roger Appelqvist, Elisabet Wieslander, Charlotte Welinder, Erika Velasquez, Natália Pinto de Almeida, Nicole Woldmar, Matilda Marko‐Varga, Krzysztof Pawłowski, Jonatan Eriksson, Beáta Szeitz, Bo Baldetorp, Christian Ingvar, Håkan Olsson, Lotta Lundgren, Henrik Lindberg, Henriett Oskolas, Boram Lee, Ethan Berge, Marie Sjögren, Carina Eriksson, Dasol Kim, Ho Jeong Kwon, Beatrice Knudsen, Melinda Rezeli, Runyu Hong, Peter Horvatovich, Tasso Miliotis, Toshihide Nishimura, Harubumi Kato, Erik Steinfelder, Madalina Oppermann, Ken Miller, Francesco Florindi, Qimin Zhou, Gilberto B. Domont, Luciana Pizzatti, Fábio C. S. Nogueira, Peter Horvath, Leticia Szadai, József Tímár, Sarolta Kárpáti, A. Marcell Szász, Johan Malm, David Fenyö, Henrik Ekedahl, István Balázs Németh, György Marko‐Varga
    Clinical and Translational Medicine 2021 11 7
  • Artificial intelligence applications for oncological positron emission tomography imaging
    Wanting Li, Haiyan Liu, Feng Cheng, Yanhua Li, Sijin Li, Jiangwei Yan
    European Journal of Radiology 2021 134
  • Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers
    David Morland, Elizabeth Katherine Anna Triumbari, Luca Boldrini, Roberto Gatta, Daniele Pizzuto, Salvatore Annunziata
    Diagnostics 2022 12 6

Article usage

Article usage: September 2019 to April 2025

AbstractFullPdf
Sep 2019391025
Oct 201991016
Nov 20199022453
Dec 20192331119
Jan 2020168611
Feb 202011882
Mar 20201021611
Apr 20206768
May 2020573620
Jun 2020512821
Jul 2020461719
Aug 202026169
Sep 2020571428
Oct 2020421820
Nov 2020231412
Dec 2020352216
Jan 2021172426
Feb 2021112114
Mar 2021132926
Apr 2021182829
May 2021173219
Jun 2021192126
Jul 202171416
Aug 2021142223
Sep 2021201833
Oct 2021102434
Nov 202192019
Dec 2021113473
Jan 2022202615
Feb 2022114592
Mar 2022153771
Apr 202272220
May 2022102026
Jun 202231718
Jul 20228175
Aug 202292129
Sep 202221416
Oct 20225914
Nov 2022103027
Dec 20229195
Jan 2023102721
Feb 20230176
Mar 2023152014
Apr 202313198
May 202351110
Jun 202352518
Jul 20232117
Aug 20234818
Sep 202322120
Oct 202351314
Nov 20236155
Dec 20232307
Jan 20246156
Feb 202431020
Mar 202421343
Apr 2024210524
May 20241259
Jun 202492311
Jul 202441115
Aug 202492415
Sep 202463010
Oct 202472913
Nov 202471012
Dec 20241187
Jan 202532931
Feb 202596213
Mar 202523616
Apr 202573626
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (6)
Journal of Nuclear Medicine
Vol. 66, Issue 6
June 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Metabolic biomarker based BRAFV600 mutation association and prediction in melanoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Metabolic biomarker based BRAFV600 mutation association and prediction in melanoma
Hanna Saadani, Bernies van der Hiel, Else A. Aalbersberg, Ioannis Zavrakidis, John B.A.G. Haanen, Otto S. Hoekstra, Ronald Boellaard, Marcel P.M. Stokkel
Journal of Nuclear Medicine Sep 2019, jnumed.119.228312; DOI: 10.2967/jnumed.119.228312

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Metabolic biomarker based BRAFV600 mutation association and prediction in melanoma
Hanna Saadani, Bernies van der Hiel, Else A. Aalbersberg, Ioannis Zavrakidis, John B.A.G. Haanen, Otto S. Hoekstra, Ronald Boellaard, Marcel P.M. Stokkel
Journal of Nuclear Medicine Sep 2019, jnumed.119.228312; DOI: 10.2967/jnumed.119.228312
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • The Dark Side of Radiomics: On the Paramount Importance of Publishing Negative Results
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Show more Clinical Investigations (Human)

Clinical (Oncology: Melanoma/Skin)

  • 18F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
  • 18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
Show more Clinical (Oncology: Melanoma/Skin)

Similar Articles

Keywords

  • Oncology: Melanoma
  • PET
  • PET/CT
  • 18F-FDG PET/CT
  • BRAF
  • melanoma
  • radiomics
SNMMI

© 2025 SNMMI

Powered by HighWire